Panaxea International

What Panaxea International does

Panaxea International is a privately held botanical medicine company that develops, manufactures, and distributes pharmaceutical GMP-grade "World Medicines" combining Chinese, Ayurvedic, and Western herbs with botanical isolates. Founded and led by Dr. Daniel Weber, DSc, PhD, who serves as CEO and Chief Medical Officer alongside COO Wilhemina Hoedeman, the company operates dual legal entities under Panaxea International, Inc. (USA, headquartered in Baldwin Park, CA) and Panaxea International Pty Ltd (Australia, ABN 55 633 428 118), with Australian TGA pharmaceutical-standard manufacturing serving as the regulatory anchor. The product line spans 109 supplements targeting complex chronic conditions including oncology (SB-120, PC2, D:FEND, Chem 1), autoimmune disease, gastrointestinal disorders (DysBio, UC, Helico-X), cardiovascular and metabolic conditions, and reproductive health, with unit pricing from approximately $14 to $135.

Revenue is generated exclusively through a gated B2B distribution model: products and authored clinical reference books are sold only to licensed healthcare practitioners who must register on panaxea.com with verifiable professional credentials (license number, association, specialty). Marketing is founder-led, relying on Dr. Weber's peer-reviewed publications in journals including SAGE Open Medicine and the Journal of Chinese Integrative Medicine, his roles as Visiting Professor at Tianjin University and Vice-chair of the WFCMS Oncology Specialty Committee, and ongoing in-person and international conference speaking. Strategic research partnerships with Tianjin University and Guang-An-Men Cancer Hospital (Beijing) provide clinical validation, including for the flagship AntiBioBotanical formula and tumor-inhibitory research.

Distribution covers four continents through the company's own e-commerce site in the US and Australia plus channel partners Bedaya Polyclinic (UAE/Dubai) and Wings Herbal (South Africa). All products are manufactured in pharmaceutical GMP factories, independently tested for heavy metals, pesticides, and contaminants, and governed by Australian TGA pharmaceutical standards rather than food-grade supplement standards.

Name

Panaxea International

Legal name

Panaxea International, Inc

Website

https://panaxea.com

Company type

Private

Founded year

1989

Operating status

Operating

Headcount range

101–250 employees

Short description

Panaxea International is a privately held botanical medicine company that manufactures pharmaceutical GMP-grade World Medicines combining Chinese, Ayurvedic, and Western herbs. It sells 109+ practitioner-only supplements and clinical reference books exclusively to licensed healthcare professionals across four continents.

Ownership category

akta.pro rank

Product category

Botanical Supplements and Integrative Medicine Manufacturing

NAICS

Medicinal and Botanical Manufacturing (325411)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Herbal & Botanical Supplements (CRADAGAD)

akta.pro secondary industries

Specialty Care Pharmaceuticals (HLAIAAAB), Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives (EUAAAIAK)

Keywords

• Botanical supplements
• Integrative oncology
• Herbal medicine
• Practitioner-grade supplements
• Pharmaceutical GMP manufacturing

Headquarters

HQ city

Baldwin Park

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Botanical Supplement Product Sales: Sale of proprietary herbal and botanical supplement formulations to licensed healthcare practitioners. Products range from approximately $14 to $129 per unit, with 109 distinct products across categories including oncology support, autoimmune, gastrointestinal, cardiovascular, and metabolic health. Practitioners purchase through the gated e-commerce platform after account registration.
2. Educational Books and Publications: Sale of clinical reference books authored by Dr. Daniel Weber, including titles such as 'Breast Cancer - A Practitioners Guide', 'Botanical Oncology; isolates', 'The Gut - Core of Self', 'Chemotherapy and Botanical Support', and others priced from $19.95 to $135.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Panaxea International manufactures and distributes a portfolio of 109+ proprietary botanical supplement formulations called 'World Medicines,' combining Chinese, Ayurvedic, and Western herbs with botanical isolates. Products are manufactured in pharmaceutical GMP factories under Australian TGA pharmaceutical standards (not food standards) and sold exclusively to licensed healthcare practitioners (naturopaths, TCM practitioners, integrative oncologists) through a gated e-commerce platform requiring professional credential verification. The company also publishes clinical reference books authored by its CEO, Dr. Daniel Weber, covering integrative oncology, autoimmune disease, and psychophysiology.

Product overview

Panaxea International is a botanical medicine company manufacturing pharmaceutical GMP-grade World Medicines formulated from Chinese, Ayurvedic, and Western Herbs along with botanical isolates. The product portfolio consists of a single unified line of practitioner-grade supplement brands and authored books. The supplement portfolio (109 items total) includes flagship products such as #1 Body (anti-ageing), FY)BROX (anti-fibrotic), Camen (reproductive/Ayurvedic), AntiBioBotanical (broad-spectrum botanical antibiotic), A1 MarkII (immunomodulating anticancer), PC2 (prostate cancer), SB-120 (breast cancer), AVIIR (antiviral), and dozens of condition-specific supplements organized across categories including oncology, autoimmune, cardiovascular, gastrointestinal, metabolic, neurological, and reproductive health. The book catalogue includes titles authored by CEO Dr. Daniel Weber covering integrative oncology, botanical medicine, psychophysiology, and autoimmune diseases. Products are only sold to licensed healthcare practitioners, not to the general public.

Differentiator

Problem solved

Functional benefit

Products and services

• #1 Body Anti-ageing formulation that stimulates tissue development and increases immunity, anabolic function, adrenal DHEA, and ATP production. For licensed healthcare practitioners.
• FY)BROX Potent anti-fibrotic formula whose ingredients work synergistically to inhibit fibrosis by inhibiting proinflammatory cytokines and TGF-beta signaling. For licensed healthcare practitioners.
• Camen Blend of Ayurvedic herbs for reproductive system support and enhancing sexual function. Increases testosterone, stimulates the hypothalamic-pituitary gonadal axis, and modulates pituitary hormones FSH and LH. For licensed healthcare practitioners.
• AntiBioBotanical World's first broad-spectrum botanical antibiotic to treat multi-drug resistant infections, usable safely alongside or in place of conventional antibiotics to clear minor resistant infections without microbiome destruction. For licensed healthcare practitioners.
• Chem 1 Combination of botanicals that alleviate side effects of chemotherapy and protect the liver and GI tract from drug toxicity. For licensed healthcare practitioners.
• PC2 Especially designed for prostate cancer patients. Helps decrease PSA count and promotes apoptosis; has antiangiogenic, cytostatic, and cytotoxic effects. Contains Ganoderma lucidum which modulates androgen receptor activation of transcription from PSA promoter in prostate cancer cells. For licensed healthcare practitioners.
• SB-120 Shows promising efficacy and excellent safety in clinical trials for advanced breast cancer. Scutellaria barbata selectively targets cancer cell mitochondria and inhibits both OXPHOS and glycolysis. For licensed healthcare practitioners.
• D:FEND Unique blend of isoflavone compounds with broad effect on tumour microenvironment. Important part of oncology protocols; can be safely used during radiotherapy to potentiate treatment outcomes and aid recovery. For licensed healthcare practitioners.
• A1 MarkII Complex blend of immunomodulating botanicals with multiple anticancer activities including inhibiting angiogenesis, modulating p53 and VEGF, lowering proinflammatory cytokines, and modulating Th1/Th2 imbalance. For licensed healthcare practitioners.
• AutoImmune 1 Unique and powerful immune support supplement for balancing immune response. Helps rebalance T-regulatory cells and cytokine response and dampens chronic inflammation that damages tissues and cells. For licensed healthcare practitioners.
• HEATOXIN Scientifically evidenced herbal formulation to protect against dysregulation of autoimmune response and modulate inflammatory factors associated with chronic diseases such as chronic inflammation, SLE, Sjogren's syndrome, and rheumatoid arthritis. For licensed healthcare practitioners.
• AVIIR (antiVIRII) Contains three of the world's best antiviral botanicals effective against H1N1, SARS, and other acute viral infections. Has strong anti-inflammatory properties to reduce lung inflammation. For licensed healthcare practitioners.
• Aviilx_long Groundbreaking formulation to specifically target the multiorgan system effects of COVID-19. For licensed healthcare practitioners.
• Berberine Complex Broad-range treatment supplement usable in oncology and SIBO protocols. Benefits include maintaining healthy cholesterol and glucose levels, eradicating unhealthy GI bacteria, and reducing chronic inflammation. For licensed healthcare practitioners.
• Past Tense For hypertension. Blends Hawthorn, Magnesium, and botanicals for treatment of hypertension. For licensed healthcare practitioners.
• LivoClear Indicated for fatty liver, hepatitis, hyperlipidaemia, and supports correction of liver damage in alcoholic and metabolic liver disease. Has antiviral effect in infective hepatitis and suited for long-term treatment. For licensed healthcare practitioners.
• Gly)Control Necessary for diabetic patients to prevent diabetic peripheral neuropathy. Combines B6, B1, and B12 with botanicals and compounds essential for nervous system integrity and blood circulation. For licensed healthcare practitioners.
• CNS factor Researched combination to increase Brain-derived neurotrophic factor (BDNF) levels in the brain. Key ingredient Schisandrin B provides adaptogenic, cognitive aid, neuroprotective, mood balancing, and anti-inflammatory effects. For licensed healthcare practitioners.
• Affect D Superior combination of botanicals and isolates for psychopharmacologic indications including PTSD, OCD, and depression. For licensed healthcare practitioners.
• Pro-Creation D Used for low progesterone, corpus luteum insufficiency, and ovarian function. Revitalising and nourishing fertility formula that up-regulates the H-P-O axis, neuroendocrine feedback mechanisms, and improves ovarian endocrine function. For licensed healthcare practitioners.
• The Gut - Core of Self Book authored by Dr. Daniel Weber on the gut as the core of self, exploring gastrointestinal health and its broader systemic impacts. For licensed healthcare practitioners.
• Chemotherapy and Botanical Support Book authored by Daniel Weber on chemotherapy and botanical support strategies for cancer care. For licensed healthcare practitioners.
• Breast Cancer A Practitioner's Guide Volume 1 and 2 Daniel Weber's latest book on breast cancer — a practitioner's guide in two volumes. For licensed healthcare practitioners.
• Botanical Oncology; isolates Comprehensive book on botanical oncology covering oriental and western approaches to herbal compounds in cancer care. Includes an online database for fast searching. For licensed healthcare practitioners.
• DUI YAO: The Art of Formula Construction Book by Daniel Weber on Dui Yao — the art of formula construction — covering modular systems of standard and exotic dui yao and classical formulas. Includes an online database. For licensed healthcare practitioners.
• Introduction to Integrative Oncology Introductory book by Daniel Weber on integrative oncology covering herbs, compounds, and supplements in the treatment of cancer. For licensed healthcare practitioners.
• A Botanical Approach to Autoimmune Diseases by Daniel Weber Book by Daniel Weber on a botanical approach to autoimmune diseases. For licensed healthcare practitioners.
• Chinese Herbal Medicine and Psychophysiology: Vagus Nerve Book by Daniel Weber on Chinese herbal medicine and psychophysiology, focusing on the vagus nerve and psychological and neurophysiological dysfunction. For licensed healthcare practitioners.
• Inflammation and the Seven Stochastic Events of Cancer Book by Daniel Weber on inflammation and the seven stochastic events of cancer. For licensed healthcare practitioners.
• Introduction to Medical Philosophy by Dr Daniel Weber Book by Daniel Weber on introduction to medical philosophy, published 2025. For licensed healthcare practitioners.

Quantifiable outcome

• Panaxea's AntiBioBotanical is described as the world's first broad spectrum botanical antibiotic for multi drug resistant infections
• +3 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration7 records

Feature5 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Tianjin UniversitycoreStrategic or Co-development PartnerDr. Daniel Weber serves as Visiting Professor at Tianjin University, where he has carried out numerous studies on Panaxea's formulations resulting in peer-reviewed journal articles. The university serves as a key research partner for clinical validation of Panaxea's botanical products.
• Bedaya Polyclinic (Dubai)minorChannel Partner/ Reseller/ DistributorBedaya Polyclinic serves as the UAE-based partner for Panaxea product distribution. Located in Dubai with contact number +971 4 333 3955 and website bedayaclinic.ae.
• Wings Herbal (South Africa)minorChannel Partner/ Reseller/ DistributorWings Herbal distributes Panaxea products in South Africa. Contact details include Tel: 080-202-88-88 / 27 21 438 2107, email: [email protected], web: wingsherbal.co.za.
• World Federation of Chinese Medical Societies (WFCMS)coreStrategic or Co-development PartnerDr. Daniel Weber holds the Vice-chairmanship of the Oncology Specialty Committee of the WFCMS, the only Westerner so honoured. He serves as editor of the Journal of Chinese Integrative Medicine, facilitating research publication and professional network connections for Panaxea.
• Guang-An-Men Cancer Hospital (Beijing, China)coreStrategic or Co-development PartnerCollaborated on in-vitro and in-vivo clinical trials for the tumor-inhibitory effects of Chinese herbal medicine AV/AT formula and isolate combinations. Research published in peer-reviewed journals (JCIM 2011).
• Viceroy Santa MonicaminorOthersViceroy Santa Monica hotel serves as the venue for Panaxea's 'Being Medicine' seminar with Dr. Daniel Weber on May 2nd, 2026 in Los Angeles.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Integrative Therapeutics: A practitioner-channel herbal and nutritional supplement brand owned by Schwabe. Comparable in exclusive professional distribution, evidence-based botanical formulations, and clinical product positioning.
• Designs for Health: A practitioner-exclusive supplement company offering professional-grade formulas for integrative medicine. Similar B2B model, professional pricing, and broad therapeutic portfolio including oncology and autoimmune categories.
• Standard Process: A US-based whole food supplement company that sells almost exclusively through healthcare practitioners. Comparable to Panaxea in B2B practitioner distribution model, clinical positioning, and broad nutritional/herbal product catalog.
• MediHerb: An Australian manufacturer of practitioner-only herbal medicines, also governed by TGA standards. Directly comparable to Panaxea in GTM (practitioner-exclusive channel), regulatory framework (TGA/GMP), and product category (clinical-grade botanicals).
• Metagenics: A practitioner-only nutraceutical and herbal medicine brand with extensive clinical product range. Comparable to Panaxea in practitioner-gated sales, TGA-equivalent quality standards, and focus on integrative medicine protocols.
• Biotics Research: A US-based nutritional supplement company distributing exclusively through healthcare practitioners. Comparable in B2B practitioner model, broad clinical product line, and emphasis on quality manufacturing standards.

Broad incumbents

• Gaia Herbs: A larger herbal supplement manufacturer with vertically integrated farming and broad DTC and practitioner presence. Comparable in botanical product category and TGA-adjacent quality focus, but with much greater scale and consumer brand recognition.
• Thorne HealthTech: A larger, publicly listed practitioner-grade supplement company with broader product portfolio, NSF Certified for Sport, and significant DTC expansion. Comparable in professional-grade positioning but operates at much greater scale with dual practitioner/consumer channels.
• Pure Encapsulations: A practitioner-recommended hypoallergenic supplement brand owned by Atrium Innovations/Nestlé Health Science. Comparable in practitioner-grade quality and clinical positioning, but with significantly broader distribution and larger parent company resources.

Emerging players

• Herb Pharm: A US-based liquid herbal extract company with strong clinical and practitioner positioning. Comparable in herbal medicine category and quality manufacturing, though primarily liquid extracts rather than Panaxea's capsule/tablet formulations.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Panaxea International